Abbott Medical Optics Fact Sheet
Abbott Medical Optics
(AMO) is a global leader in ophthalmic care, comprised of three segments:
cataract surgery/intraocular lens (IOL), laser vision correction and eye care
products. It is based in Santa Ana, Calif., and had 2008 sales of $1.2 billion.
Primary Businesses
- Cataract Surgery/IOL: Devices for cataract surgery, which replaces a
patient's aging and cloudy natural lens with an IOL or artificial lens to
restore vision.
- Laser Vision Correction (LASIK): Devices used for refractive laser
eye surgery to correct myopia (nearsightedness), hyperopia (farsightedness) and
astigmatism (condition that causes blurred vision).
- Eye Care: Contact lens care products including multi-purpose
cleaning and disinfecting solutions, daily cleaners and contact lens rewetting
drops; and over-the-counter dry eye products.
AMO's headquarters building in Santa Ana, Calif.
Products
- Cataract Surgery/IOL: WhiteStar Signature™ Phacoemulsification
System, Healon® Viscoelastics, Tecnis® Aspheric IOL, Tecnis® Multifocal IOL,
ReZoom® Multifocal IOL.
- Laser Vision Correction (LASIK): iLASIK™, VISX™ Excimer Technology,
IntraLase™ FS Technology, Advanced CustomVue™ Procedure.
- Eye Care: COMPLETE® Multi-Purpose Solution, Blink Contacts™
Lubricant Eye Drops, Oxysept® UltraCare Formula, Blink® Tears Lubricating Eye
Drops.
Vision Facts
- About 60 percent of people 60+ years old have cataracts.
- The global population is aging at unprecedented levels. There are more than
700 million people globally older than 60 (up
from 600 million in 2000); by 2020, this number
is projected to increase to 1 billion.
- Cataracts are the leading cause of vision loss among people 55 and
older.
- More than 15 million cataract procedures are performed worldwide
annually.
- Approximately 52 percent of people have some form of myopia or
hyperopia.
- More than 3.5 million LASIK procedures are performed globally annually;
LASIK accounts for more than 90 percent of all U.S. refractive surgical
procedures.
Additional Information: